Atreides Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000,000
Closed -$52.4M 59
2024
Q3
$52.4M Buy
+1,000,000
New +$46.9M 1.33% 25

Other funds holding ALAB

Atreides Management's ALAB Position: Q1 2026 in Review

Atreides Management increased its Astera Labs (ALAB) stake by 109% in Q1 2026, buying an estimated $250M and bringing the position to 3,365,787 shares worth $369M. The position accounts for 7.37% of the portfolio, ranked #2.

Atreides Management first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $376M in Q3 2024. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Atreides Management held 3,365,787 shares of Astera Labs worth $369M as of Q1 2026.
  • Atreides Management bought 1,754,593 Astera Labs shares in Q1 2026, an estimated $250M.
  • Astera Labs made up 7.37% of Atreides Management's portfolio in Q1 2026, its #2 holding.
  • Atreides Management first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • Atreides Management's Astera Labs position peaked at $376M in Q3 2024.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Atreides Management's 13F filing for Q1 2026, filed 18 May 2026.